News Release Details

Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

May 2, 2023

SAN DIEGO--(BUSINESS WIRE)--May 2, 2023-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following upcoming investor conferences:

BofA Securities 2023 Health Care Conference
Fireside Chat: Wednesday, May 10, 2023 at 2:20 p.m. Eastern Time in Las Vegas, NV

The JMP Securities Life Sciences Conference
Fireside Chat: Tuesday, May 16, 2023 at 2:30 p.m. Eastern Time in New York, NY

2023 RBC Capital Markets Global Healthcare Conference
Fireside Chat: Wednesday, May 17, 2023 at 1:35 p.m. Eastern Time in New York, NY

Live webcasts of the presentations will be accessible on the company’s website,, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals

Acadia is advancing breakthroughs in neuroscience to elevate life. For almost 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapies for hallucinations and delusions associated with Parkinson’s disease psychosis and for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Alzheimer’s disease psychosis and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at and follow us on LinkedIn and Twitter.

Media Contact:
Acadia Pharmaceuticals Inc.
Deb Kazenelson
(818) 395-3043

Investor Contact:
Acadia Pharmaceuticals Inc.
Mark Johnson, CFA
(858) 261-2771

Source: Acadia Pharmaceuticals Inc.

Investors Contact

Click here to contact Investor Relations.

Email Alerts

Click here to sign up for email alerts.